Mesenchymal Stem Cells Beyond Regenerative Medicine
Mesenchymal stem cells (MSCs) are competent suitors of cellular therapy due to their therapeutic impact on tissue degeneration and immune-based pathologies. Additionally, their homing and immunomodulatory properties can be exploited in cancer malignancies to transport pharmacological entities, produ...
Main Authors: | Riam Shammaa, Abed El-Hakim El-Kadiry, Jamilah Abusarah, Moutih Rafei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00072/full |
Similar Items
-
Cell Therapy: Types, Regulation, and Clinical Benefits
by: Abed El-Hakim El-Kadiry, et al.
Published: (2021-11-01) -
Autologous BMAC Therapy Improves Spinal Degenerative Joint Disease in Lower Back Pain Patients
by: Abed El-Hakim El-Kadiry, et al.
Published: (2021-03-01) -
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
by: Jean-Pierre Bikorimana, et al.
Published: (2022-02-01) -
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
by: Jean-Pierre Bikorimana, et al.
Published: (2022-12-01) -
CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties
by: Jean-Pierre Bikorimana, et al.
Published: (2022-07-01)